8:00 am – Registration and Breakfast
9:00 am – Introductory Remarks
Emilio Ragosa
9:15 am – Diplomacy, Disruption, and Direction:
A Fireside Chat on US Global Engagement
Senator Richard Burr, Ambassador Marc Grossman (The
Cohen Group), and Emilio Ragosa
9:45 am – Legal Strategy for Life Sciences in a
Tariff-Era Economy: Incentives, Trade, and Strategic
Site Selection
Stephanie Yarbrough and Ting Xiao
10:15 am – Bridging Science and Strategy:
Collaborations that Deliver
Tracy Dowling (AskBio), Jared Freedberg
(Arvinas), Sonia de Kondserovsky, Lauren
Murdza, and Aurely Vervondel (argenx)
10:45 am – Coffee Break
11:15 am – Transforming Life Sciences with AI:
Real-World Use Cases and Emerging Frontiers
Larissa Bifano, Denise Butler (Johnson & Johnson),
Ittai Dayan (Rhino Federated Computing), Kristina Kitko
(Eli Lilly), Allen Waxman, and Camille Whicker
(Microsoft)
12:00 pm – Global M&A Life Sciences Outlook
and Adapting to the Current Market Dynamics
David Clark, Emilio Ragosa, and Victoria Rhodes
12:30 pm – Lunch and Networking
1:30 pm – The Price Is Right, or Is It?
What’s Next in Drug Pricing Policy
Kirsten Axelsen, Ellen Lukens (Health Transformation
Strategies), and Preeya Pinto
2:00 pm – FDA at the Crossroads: How
Evolving Regulatory Priorities Are Affecting Global
Life Sciences Companies
Kenita Barrow (Otsuka America Pharmaceutical, Inc.),
Sarah Karlgaard (Fujifilm Holdings American
Corporation), and Vernessa Pollard
2:30 pm – Navigating Global Product
Liability: Legal Trends and the EU’s New
Rules
Cara Edwards, Mary Gately, Jeremy Sher, and Michael W.
King (Jazz Pharmaceuticals)
3:00 pm – Fun snack and Coffee
break
3:30 pm – Managing Business Views of LOE
(Loss of Exclusivity) in Real Time: Patent Expiration
and Global IP Strategy
Jenny Alonso (Neurelis), Nicole Endejann, Ray Miller,
Aoife Murphy, Nick Tyacke, and Dr. Irfan Qureshi
(Biohaven)
4:15 pm – Compliance and Investigations:
Navigating an Uncertain Enforcement
Environment
Eric Christofferson, Lisa Kutlin (Pfizer), Lisa
LeCointe-Cephas (Johnson & Johnson Innovative
Medicine), Dana McMahon (Stryker), and Jeff Scott
5:00 pm – The EU Life Sciences Landscape:
Trends, Risks, and Opportunities
Marco de Morpurgo and Stefano Marino
5:30 pm – Closing Remarks
Sang Kim
5:30 pm – Cocktail Reception
58b6.jpg?h=975&iar=0&w=2560)
